Tonix Pharmaceuticals Holding Corp.   NASDAQ (TNXP)

-0.02    $-5.21   6.18%
At close   Friday, Dec 03 04:00 PM

Tonix Pharmaceuticals Holding Corp. Chart

TNXP Stock Price Today

Tonix Pharmaceuticals Holding Corp. (TNXP) stock rallied over 6.18% intraday to trade at $-0.02 a share on NASDAQ. The stock opened with a gain of 11.36% at $0.49 and touched an intraday high of $0.5095, rising 15.80% against the last close of $0.44. The stock went to a low of $0.4809 during the session.

Stock Snapshot

0.44
Prev. Close
0.49
Open
192.50M
Market Cap
366.43M
Number of Shares
0.4809
day Low
0.5095
Day High
-0.02
-
P/E ratio
1.74%
Free Float in %
-0.30
EPS (TTM)
0.55
Book Value per Share
0.39
Cash Flow per Share
10.71M
Volume

Tonix Pharmaceuticals Holding Corp. Historical Data

DateOpenCloseDaily HighDaily LowVolume
2021-12-03$0.43$0.41$0.44$0.4110,759,710
2021-12-02$0.41$0.44$0.44$0.4114,656,400
2021-12-01$0.46$0.43$0.47$0.4329,550,600
2021-11-30$0.48$0.47$0.49$0.4620,728,600
2021-11-29$0.52$0.48$0.52$0.4838,445,400
2021-11-26$0.49$0.51$0.51$0.4824,924,900
2021-11-24$0.49$0.48$0.49$0.4634,726,500
2021-11-23$0.56$0.49$0.57$0.4878,051,100
2021-11-22$0.49$0.47$0.49$0.4624,806,000
2021-11-19$0.50$0.48$0.51$0.4820,001,300
2021-11-18$0.53$0.51$0.53$0.5015,342,200

Contact Details

26 Main Street
Suite 101
Chatham, NJ 07928
United States
http://www.tonixpharma.com
212 980 9155

About Company

Tonix Pharmaceuticals Holding Corp. discovers, acquires, develops, and licenses small molecules and biologics to treat and prevent human diseases and alleviate suffering. Its immunology product candidates include vaccines to prevent infectious diseases and biologics to address immunosuppression, cancer, and autoimmune diseases; and central nervous system (CNS) product candidates comprise small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. The company's lead vaccine candidate is TNX-1800, a live replicating vaccine based on the horsepox viral vector platform to protect against COVID-19. Its vaccines also comprise TNX-801, a live horsepox virus vaccine to protect against smallpox and monkeypox and serves as the vector platform; and TNX-2300 for the prevention of COVID-19. The company's lead CNS candidate is TNX-102 SL, a sublingual tablet formulation of cyclobenzaprine for fibromyalgia, and for the treatment of agitation in Alzheimer's disease, posttraumatic stress disorder (PTSD), and alcohol use disorder. Its products include TNX-1300 for the treatment of cocaine intoxication; TNX-601 CR for depression disorder, PTSD, and neurocognitive dysfunction from corticosteroids; and TNX-1900 for migraine and craniofacial pain treatment. Its preclinical pipeline includes TNX-1600 for PTSD, depression, and attention deficit hyperactivity disorder; TNX-1700 for gastric and pancreatic cancers; TNX-701 for radioprotection; TNX-1200, a smallpox vaccine; TNX-1500, a monoclonal antibody anti-CD40-L for organ transplant rejection autoimmunity; and TNX-2900, an intranasal potentiated oxytocin for the treatment of Prader-Willi syndrome. It also develops TNX-2100, a COVID-19 skin test. It has collaboration agreements with Southern Research Institute, Columbia University, the University of Alberta, and Massachusetts General Hospital. The company was incorporated in 2007 and is headquartered in Chatham, New Jersey.

Frequently Asked Questions

What is the current Tonix Pharmaceuticals Holding Corp. (TNXP) stock price?

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) stock price is $-0.02 as of the last check on Friday, Dec 03. During the trading session, TNXP stock reached the peak price of $0.5095 while $0.4809 was the lowest point it dropped to.

TNXP's industry and sector of operation?

The NASDAQ listed TNXP is part of Biotechnology industry that operates in the broader Healthcare sector. Tonix Pharmaceuticals Holding Corp. discovers, acquires, develops, and licenses small molecules and biologics to treat and prevent human diseases and alleviate suffering.

Who are the executives of TNXP?

Dr. Seth Lederman
Co-Founder, Pres, CEO & Chairman

Mr. Bradley Saenger CPA, CPA
CFO & Treasurer

Dr. Gregory M. Sullivan
Chief Medical Officer & Sec.

Mrs. Jessica Edgar Morris
Chief Operating Officer


What is the TNXP stock price today?

TNXP stock traded closed the last session at $-0.02, which is $-5.21 or 6.18% higher than its previous close of $0.44. TNXP's current trading price is -80.42% lower than its 52-week high of $2.12 where as its distance from 52-week low of $0.41 is 1.22%.

How many employees does TNXP have?

Number of TNXP employees currently stands at 26. TNXP operates from 26 Main Street Suite 101 Chatham, NJ 07928 United States.

Link for TNXP official website?


How do I contact TNXP?

TNXP could be contacted at 26 Main Street Suite 101 Chatham, NJ 07928 United States, or at phone # 212 980 9155 and can also be accessed through its website: http://www.tonixpharma.com

How many shares of TNXP are traded daily?

TNXP stock volume for the day was 10.71M shares while in the previous session number of TNXP shares traded was 10.76M. The average number of TNXP shares traded daily for last 3 months was 15.96M.

How much did TNXP change today?

The percentage change in TNXP stock occurred in the recent session was 6.18% while the dollar amount for the price change in TNXP stock was $-5.21.

What price range TNXP stock been trading in?

In the recent session, the day high for TNXP stock was $0.5095 while the low for TNXP stock touched on the day was $0.4809.

What is the market cap of TNXP currently?

The market value of TNXP currently stands at $192.50M with its latest stock price at $-0.02 and 366.43M of its shares outstanding.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam